![]() |
市場調查報告書
商品編碼
1319285
注射泵市場:2019-2029年全球市場規模、佔有率、趨勢分析、機遇和預測報告Syringe Pump Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Type ; By Application ; By End User ; By Region |
由於家庭醫療保健服務趨勢的不斷成長、注射泵技術進步的快速採用以及慢性病患病罹患率的上升,全球注射泵市場正在蓬勃發展。
領先的戰略諮詢和市場研究公司BlueWeave Consulting最近預計,2022年全球注射泵市場規模將達到218.9億美元。 BlueWeave 預測,2023 年至 2029 年預測期內,全球注射泵市場規模將以 6.3% 的年複合成長率大幅成長,2029 年達到 333.7 億美元。全球注射泵市場的主要成長促進因素包括慢性病患病率的增加、人口老齡化的加劇、注射泵設備的技術進步以及對準確和安全的給藥系統的需求不斷增加。根據全球癌症觀察站的數據,2020 年將有大約 19,292,789 例新的癌症診斷。不同性別和年齡層中因癌症死亡的總人數估計約為 9,958,133 人。其中乳腺癌、肺癌、結直腸癌、前列腺癌、胃癌是今年的主流癌症。這些統計數據預計在未來幾年將出現顯著成長,並將推動注射泵市場的發展。外科手術數量的增加預計也將推動全球注射泵市場的發展。知名市場進入者增加的投資和新產品的推出預計將為預測期內的市場成長創造有利的預測。然而,嚴格的監管要求和注射泵的高成本預計將限制全球注射泵市場。
該報告的詳細分析提供了有關全球注射泵市場的成長潛力、未來趨勢和統計數據的資訊。它還涵蓋了推動市場總規模預測的因素。該報告致力於為決策者提供全球注射泵市場的最新技術趨勢以及行業見解,以做出明智的戰略決策。它還分析了市場的成長促進因素、挑戰和競爭動態。
Global syringe pump market is flourishing because of an increasing trend toward home-based healthcare services, rapid adoption of advancements in syringe pump technology, and rising incidence of chronic diseases.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global syringe pump market size at USD 21.89 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global syringe pump market size to grow at a significant CAGR of 6.3% reaching a value of USD 33.37 billion by 2029. Major growth drivers for the global syringe pump market include an increasing prevalence of chronic diseases, the growing geriatric population, technological advancements in syringe pump devices, and the rising demand for accurate and safe drug delivery systems. According to the Global Cancer Observatory, there were approximately 19,292,789 newly diagnosed cancer cases in 2020. Among individuals of various genders and age groups, the total number of fatalities attributed to cancer was estimated to be around 9,958,133. Notably, breast cancer, lung cancer, colorectal cancer, prostate cancer, and stomach cancer were the prevailing types of cancer during that year. It is expected that these statistics will experience significant growth in the coming years, thereby driving the advancement of the syringe pump market. Also, the expansion in the volume of surgical procedures conducted is expected to facilitate the development of the worldwide syringe pump market. The rise in investments and the introduction of novel products by prominent market participants are projected to generate profitable prospects for market growth during the forecast period. However, stringent regulatory requirements and high cost of syringe pumps are anticipated to restrain the global syringe pump market.
The global syringe pump market refers to the collective market for medical devices that are designed to deliver precise and controlled amounts of fluids or medications to patients. Syringe pumps are commonly used in healthcare settings, including hospitals, clinics, and ambulatory care centers, to administer various therapies, such as intravenous infusions, pain management, anesthesia, neonatal care, and chemotherapy. These devices provide accurate and controlled delivery of medications, ensuring patient safety and therapeutic efficacy. The market encompasses a range of syringe pump types, including traditional syringe pumps used in clinical settings and ambulatory syringe pumps designed for portable use. With advancements in technology, syringe pumps now often incorporate features such as wireless connectivity and integration with electronic health record (EHR) systems to enhance functionality and streamline patient care. The global syringe pump market is driven by factors such as the increasing prevalence of chronic diseases, the growing aging population, demand for safe and accurate drug delivery systems, and technological advancements in syringe pump devices.
COVID-19 pandemic had a dual impact on the global syringe pump market. There was a surge in demand for syringe pumps due to the increased need for accurate medication delivery in critical care settings. The pandemic highlighted the importance of syringe pumps in delivering medications, including vaccines and critical care drugs. Also, syringe pumps and ventilators hold significant importance as essential devices used in intensive care units (ICUs), cardiac care units (CCUs), and emergency rooms. In COVID wards, intravenous (IV) infusion is a common requirement. Infusion pumps play a vital role in monitoring and delivering precise drug doses in hospitals and emergency rooms, enabling healthcare professionals to treat patients while minimizing the risk of infection, as they can be programmed to operate without constant observation. Consequently, the demand for infusion pumps experienced a sharp surge in 2020. Hospitals confronted with the novel coronavirus faced shortages of ventilators, personal protective equipment, and infusion pumps, all of which were crucial for managing the increasing number of COVID-19 patients.
Major players operating in the global syringe pump market include: BD, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Terumo Corporation, Smith's Medical, Moog Inc., B. Braun Melsungen AG, Hospira, Inc., Nipro Corporation, Mindray Medical International Limited, Roche Diagnostics, Zyno Medical, KD Scientific, and NIKKISO CO., LTD. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Syringe Pump Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Syringe Pump Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.